Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Trevena Inc (TRVN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Trevena Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1429560.
Total stock buying since 2014: $6,947,122.
Total stock sales since 2014: $565,842.
Total stock option exercises since 2014: $75,294.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2022 | 0 | $0 | 31,785 | $13,031 | 0 | $0 |
2021 | 56,200 | $100,541 | 0 | $0 | 0 | $0 |
2019 | 157,500 | $161,700 | 0 | $0 | 0 | $0 |
2018 | 0 | $0 | 5,000 | $8,800 | 0 | $0 |
2017 | 0 | $0 | 0 | $0 | 110,403 | $75,294 |
2016 | 43,584 | $246,483 | 0 | $0 | 0 | $0 |
2015 | 0 | $0 | 27,217 | $287,139 | 0 | $0 |
2014 | 1,609,500 | $6,438,398 | 42,446 | $256,872 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2022-06 | 0 | $0 | 31,785 | $13,031 | 0 | $0 |
2021-06 | 56,200 | $100,541 | 0 | $0 | 0 | $0 |
2019-05 | 7,500 | $8,700 | 0 | $0 | 0 | $0 |
2019-02 | 150,000 | $153,000 | 0 | $0 | 0 | $0 |
2018-03 | 0 | $0 | 5,000 | $8,800 | 0 | $0 |
2017-02 | 0 | $0 | 0 | $0 | 110,403 | $75,294 |
2016-11 | 21,500 | $89,209 | 0 | $0 | 0 | $0 |
2016-05 | 22,084 | $157,274 | 0 | $0 | 0 | $0 |
2015-12 | 0 | $0 | 27,217 | $287,139 | 0 | $0 |
2014-12 | 1,609,500 | $6,438,398 | 0 | $0 | 0 | $0 |
2014-09 | 0 | $0 | 44 | $308 | 0 | $0 |
2014-08 | 0 | $0 | 42,402 | $256,564 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-06-28 | Shin Barry (SVP, CFO) | Sale | 31,785 | .41 | 13,031 |
2021-06-28 | Bourdow Carrie L. (President & CEO) | Buy | 56,200 | 1.79 | 100,541 |
2019-05-31 | Hamill John P. (VP Fin,Princ Fin&Acct Officer) | Buy | 7,500 | 1.16 | 8,700 |
2019-02-01 | Gowen Maxine (President & CEO) | Buy | 50,000 | 1.02 | 51,000 |
2019-02-01 | Moulder Leon O Jr (Director) | Buy | 100,000 | 1.02 | 102,000 |
2018-03-22 | Habib Yacoub (SVP, Bus Dev & Corp Planning) | Sale | 5,000 | 1.76 | 8,800 |
2017-02-23 | Gowen Maxine (President & CEO) | Option Ex | 110,403 | .68 | 75,294 |
2016-11-09 | Bourdow Carrie L. (SVP, Chief Commercial Officer) | Buy | 4,000 | 4.34 | 17,360 |
2016-11-07 | Habib Yacoub (SVP, Bus Dev & Corp Planning) | Buy | 5,000 | 4.12 | 20,600 |
2016-11-07 | Gowen Maxine (President & CEO) | Buy | 12,500 | 4.10 | 51,249 |
2016-05-27 | Gowen Maxine (President & CEO) | Buy | 14,084 | 7.08 | 99,714 |
2016-05-26 | Gowen Maxine (President & CEO) | Buy | 8,000 | 7.20 | 57,560 |
2015-12-10 | Soergel David (Sr. VP,Clinical Dev. & CMO) | Sale | 27,217 | 10.55 | 287,139 |
2014-12-12 | Limongelli John M (Sr. VP,General Counsel & Secy) | Buy | 3,000 | 4.14 | 12,419 |
2014-12-10 | Yanni Barbara (Director) | Buy | 1,250 | 4.00 | 5,000 |
2014-12-10 | Lark Michael W. (Sr. VP, Research & CSO) | Buy | 5,000 | 4.00 | 20,000 |
2014-12-10 | Soergel David (Sr. VP, Clinical Development) | Buy | 1,250 | 4.00 | 5,000 |
2014-12-10 | Cuca Roberto (Sr. VP and CFO) | Buy | 25,000 | 4.00 | 100,000 |
2014-12-10 | Limongelli John M (Sr. VP,General Counsel & Secy) | Buy | 9,000 | 4.00 | 36,000 |
2014-12-10 | Gowen Maxine (President & CEO) | Buy | 8,000 | 4.00 | 32,000 |
2014-12-10 | Sandell Scott D (10% Owner) | Buy | 1,000,000 | 4.00 | 4,000,000 |
2014-12-10 | Moulder Leon O Jr (Director) | Buy | 19,800 | 4.06 | 80,387 |
2014-12-10 | Nohra Guy P (10% Owner) | Buy | 500,000 | 4.00 | 2,000,000 |
2014-12-10 | Dougherty Michael R (Director) | Buy | 7,000 | 4.00 | 28,000 |
2014-12-09 | Moulder Leon O Jr (Director) | Buy | 30,200 | 3.96 | 119,592 |
2014-09-29 | Deegan Rosamond (Sr VP, Bus Dev & Operations) | Sale | 44 | 7.00 | 308 |
2014-08-14 | Flint Jonathan A (10% Owner) | Sale | 36,702 | 6.04 | 221,680 |
2014-08-13 | Flint Jonathan A (10% Owner) | Sale | 5,700 | 6.12 | 34,884 |
Insider trading activities including stock purchases, stock sales, and option exercises of TRVN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Trevena Inc (symbol TRVN, CIK number 1429560) see the Securities and Exchange Commission (SEC) website.